Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.
about
The CXCL8-CXCR1/2 pathways in cancerNickel and the microbial toxin, MALP-2, stimulate proangiogenic mediators from human lung fibroblasts via a HIF-1alpha and COX-2-mediated pathwayKnockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesisELR+ CXC chemokine expression in benign and malignant colorectal conditionsEffects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells.Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaSmoking and lung cancer: the role of inflammation.Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expressionExpression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features.EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical featuresRole of chemokines in tumor growth.Evolving concepts in lung carcinogenesisCXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancerCancer cell signaling pathways targeted by spice-derived nutraceuticals.Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.Inflammation and lung carcinogenesis: applying findings in prevention and treatment.Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment.Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells.PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinomaCyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis.Eicosanoids in inflammation and cancer: the role of COX-2.Tumor microenvironment is multifaceted.Nuclear factor-κB: a key regulator in health and disease of lungs.The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.Multifaceted link between cancer and inflammation.Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: An Update.Cancer and inflammation.EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells.Alteration in metastasis potential and gene expression in human lung cancer cell lines by ITGB8 silencing.Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.Interleukin-8 derived from local tissue-resident stromal cells promotes tumor cell invasion.Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.Secretion of wound healing mediators by single and bi-layer skin substitutes.Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.The clinical significance of CXCL5 in non-small cell lung cancer.
P2860
Q28075994-8C35FA9D-4CBC-4C11-9FB1-71E1BED9188DQ28387389-395CEF8C-485F-4C3F-9105-63173147B06DQ28396291-1C1E4C6C-CC9F-423A-B96C-427A8CA1A0DBQ33346619-8ECF8972-5757-4434-A55C-023FE6FD1142Q33356757-5E6EAAC4-4C27-48F8-B419-F7DC08592C58Q33437576-A2376DDF-2D69-4C28-A82B-1218FE60A2B8Q33646333-32847AAA-3717-4589-ACE9-9E0D3505F57CQ33842487-116DB82C-1A31-44B9-9C56-22410A902158Q33956097-B6F07030-D58C-48F0-B257-B66CF764CC50Q34066293-833E6508-C190-404D-B616-B4E8F2863F4FQ34712741-5A5CA7D5-476A-4E69-9EE1-848B90A5EBE3Q36120825-779AE78C-426A-4CAE-A682-F6B3D94519DEQ36178320-F35584B8-E811-4C9B-8A08-0D928219CAD7Q36228506-5077BD77-261A-4F39-AF00-74EE8A1F3C8DQ36819371-0DD06702-CD42-48FB-AE81-3DB8F9B1D9A6Q36892544-47898008-BA8C-402F-9080-8D5F000190D4Q36974700-A01A19C2-EA7B-4DCF-A2D1-E60EEF4984F2Q37096361-0BB629D6-A0AD-4B55-9131-C0D43D64269CQ37134013-FB187B71-11BA-4252-9AD1-741DA3509781Q37193568-1BBB8ADE-3ACC-4B9B-9D18-B6ECAF1F18D1Q37266333-6D48A674-EA4A-41B7-A1DD-529D86690BA2Q37400654-45DCF2D8-9CB1-48E8-BCAC-72CA734D039FQ37754720-4F7EEE7D-62B1-4920-A0D8-AB027A35C5A2Q37832693-286DC2E8-6E04-4132-B327-8732767C09B0Q37904904-5EFE8ABB-CBAE-40F2-8F3F-BB41FA58B178Q37933095-42876E9A-4397-4535-824D-08DA0A2AF357Q37943405-4AEC8BD8-5C1D-4C70-A34D-5B7552C70F29Q38669280-EB7FA250-B5CB-4473-8C0B-B286BDFAE45EQ39036378-882D749D-4E60-48B7-8D65-B786F4C052A1Q39241053-AD15E913-D37A-465E-BBCA-1DB73C8CED5BQ39321381-2CDACEE9-ECC3-4763-B51F-2CF9A70660FEQ39396200-343E62F3-1017-43F4-B44C-3319F7B42F2DQ39481178-481E9C58-0A3B-43B3-B9E0-F38BA7548BC6Q40180995-5FDFADD6-5995-4375-A2A6-69CACA7C387DQ40724369-61618D27-1579-416D-90F8-132F4779E523Q41639634-8864EED9-6049-4ACA-8537-579EC36ACC3EQ42036547-0D034989-3C8B-41FD-9E66-9379A986F129Q45881022-BABB8822-CDAB-402B-A3FC-BF23734E5933Q46586534-44B8BE62-E36B-4CAD-A475-52D76202C35CQ47101861-B13250BA-9D25-4856-8BE9-9B684A17CB7F
P2860
Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cyclooxygenase-2-dependent exp ...... an non-small cell lung cancer.
@en
type
label
Cyclooxygenase-2-dependent exp ...... an non-small cell lung cancer.
@en
prefLabel
Cyclooxygenase-2-dependent exp ...... an non-small cell lung cancer.
@en
P2093
P1433
P1476
Cyclooxygenase-2-dependent exp ...... an non-small cell lung cancer.
@en
P2093
Jenny T Mao
Kostyantyn Krysan
Mariam Dohadwala
Marie D Burdick
Mehis Põld
Peter P N Lee
Raj K Batra
P304
P356
10.1158/0008-5472.CAN-03-3262
P407
P577
2004-03-01T00:00:00Z